BAIOO(02100) Chairman Dai Jian acquired a total of 100,000 shares.
Bai'ao Family Interactive (02100) announced that Mr. Dai Jian, an executive director and chairman of the board, purchased a total of 100,000 ordinary shares of the company with a face value of $0.0000005 per share at an average price of 0.460 Hong Kong dollars per share through Stmoritz Investment Limited (Stmoritz, a company indirectly owned by Mr. Dai) on April 9, 2026.
BAIOO (02100) announced that Mr. Dai Jian, an executive director and chairman of the Board, purchased a total of 100,000 shares of the company's ordinary shares at an average price of HK$0.460 per share through Stmoritz Investment Limited (Stmoritz, a company indirectly owned by Mr. Dai) on April 9, 2026, each with a face value of US$0.0000005.
Following the purchase of the shares, Stmoritz directly owns a total of 689 million shares (approximately 24.0% of the company's issued share capital).
From March 30 to April 9, 2026, Mr. Dai purchased a total of 1.476 million shares through Stmoritz.
Related Articles
S HARBOURHOLD (01663) Chairman and major shareholder Wang Linbing increased his holdings by 3.45 million shares.
China Baoli Technology (00164) issues 38.44 million subscription shares.
Beijing Hotgen Biotech Co., Ltd (688068.SH) subsidiary's innovative drug SGT003 injection has received the "Acceptance Notice" for clinical trial application.
S HARBOURHOLD (01663) Chairman and major shareholder Wang Linbing increased his holdings by 3.45 million shares.
China Baoli Technology (00164) issues 38.44 million subscription shares.
Beijing Hotgen Biotech Co., Ltd (688068.SH) subsidiary's innovative drug SGT003 injection has received the "Acceptance Notice" for clinical trial application.
RECOMMEND
